Epic Bio is a biotechnology company that develops advanced gene regulation technologies designed to address unmet medical needs. Founded by Stanley Qi, one of the original inventors of CRISPR, Epic Bio employs a novel approach to manipulate the epigenome, allowing for the activation and suppression of multiple genes simultaneously without cutting DNA. This unique platform aims to create a new class of therapeutics that can effectively target complex diseases influenced by multiple genetic factors. The company is dedicated to building a collaborative environment where talented individuals can contribute to groundbreaking research and innovation in gene therapy, making a meaningful impact in the field of medicine.